Monocarboxylate Transporter (MCT) Inhibitors
Learn MoreHistone Acetyltransferase (HAT) inhibitors are innovative compounds that have the ability to modulate gene expression by targeting the enzymes responsible for adding acetyl groups to histone proteins Histone acetylation is a key epigenetic modification that affects DNA accessibility and ultimately regulates gene transcription By inhibiting HAT activity these inhibitors offer a powerful tool for studying the role of specific genes and pathways in cellular processes Additionally they hold great potential for therapeutic applications by selectively targeting dysregulated gene expression in diseases such as cancer and neurodegenerative disorders Our company offers a range of high-quality Histone Acetyltransferase (HAT) inhibitors to support research efforts and advance the understanding of epigenetic mechanisms
Catalog Number | Chemical Name | CAS # | Price |
---|---|---|---|
BC-0545 | CPTH2 (hydrochloride) | 2108899-91-6 | Online Inquiry |
BC-0552 | Delphinidin (chloride) | 528-53-0 | Online Inquiry |
BC-0636 | Plumbagin | 481-42-5 | Online Inquiry |
BC-0682 | (-)-Epigallocatechin gallate | 989-51-5 | Online Inquiry |
BC-0696 | Curcumin, Curcuma longa (High Purity) | 458-37-7 | Online Inquiry |
EI-0085 | A-485 | 1889279-16-6 | Online Inquiry |
EI-0189 | Anacardic Acid | 16611-84-0 | Online Inquiry |
EI-0483 | C646, p300/CBP Inhibitor | 328968-36-1 | Online Inquiry |
EI-0804 | EML-425 | 1675821-32-5 | Online Inquiry |
EI-1029 | Garcinol | 78824-30-3 | Online Inquiry |
EI-1517 | MOZ-IN-3 | 2055397-18-5 | Online Inquiry |
EI-1865 | Remodelin | 949912-58-7 | Online Inquiry |
EI-2306 | WM-1119 | 2055397-28-7 | Online Inquiry |
EI-2760 | Butyrolactone 3 | 778649-18-6 | Online Inquiry |
EI-2762 | CAY10669 | 1243583-88-1 | Online Inquiry |
Histone Acetyltransferase (HAT) inhibitors have a wide range of applications in both research and medicine In the field of research these inhibitors are used to study the role of histone acetylation in gene regulation and disease By inhibiting HAT activity scientists can better understand the impact of histone acetylation on chromatin structure and gene expression leading to new discoveries and insights into various biological processes
In medicine HAT inhibitors are explored as potential therapeutic agents for diseases such as cancer and neurodegenerative disorders Aberrant histone acetylation patterns have been linked to the development and progression of these conditions By targeting HAT enzymes with inhibitors it is possible to modulate histone acetylation levels and potentially restore normal gene expression patterns providing a potential avenue for novel treatment approaches
Overall the applications of HAT inhibitors are multifaceted offering opportunities for groundbreaking research and the development of innovative therapies in the field of biology and medicine
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.